Authors
Latest:
Spending Variation Among ACOs in the Medicare Shared Savings ProgramAnalysis of spending differences among accountable care organizations (ACOs) may help identify cost savings opportunities. We examined the magnitude and sources of spending variation among ACOs over 4 years.
Latest:
Impact of a Value-Based Formulary in Three Chronic Disease CohortsA value-based formulary was implemented that used cost-effectiveness analysis to inform medication co-payments. Diabetes cohort expenditures decreased by $9 per member per month.
Latest:
Bending the Curve Through Health Reform ImplementationAuthors from The Brookings Institution update their recommendations by focusing on 3 concrete objectives to slow spending and improve quality of care within the next 5 years.
Latest:
The Utility of Cost Discussions Between Patients With Cancer and OncologistsMany patients with cancer desire cost discussions with doctors, but those discussions are rare. Nevertheless, cost discussions may lower patient costs-usually without altering treatment.
Latest:
Measures of ED Utilization in a National Cohort of ChildrenThrough analysis of multistate Medicaid data, this study identifies differences in 2 commonly used measures of emergency department (ED) utilization, ED visit count and ED reliance.
Latest:
Patient Safety Intervention to Reduce Unnecessary Red Blood Cell UtilizationThis study evaluated the impact of a patient safety intervention and national guideline to reduce unnecessary red blood cell transfusions in a large, urban academic medical center.
Latest:
Distal Upper and Lower Limb Fractures Associated With Thiazolidinedione UseThis study demonstrates that patients with diabetes taking thiazolidinediones have higher proportions of distal upper and lower limb fractures than those not taking the drug.
Latest:
Collaborative DTM Reduces Hospitalization and Healthcare Costs in Patients With Diabetes Treated With PolypharmacyDrug therapy management implementation in 2 health plans resulted in significant cost savings and modest to significant reductions in emergency department visits and inpatient admissions among patients with diabetes.
Latest:
A Claims-Based Algorithm to Reduce Relapse and Cost in SchizophreniaImplementing a claims-based algorithm and disease management program may be an effective strategy to reduce relapse and cost among patients with schizophrenia.
Latest:
Pragmatic Clinical Trials: US Payers' Views on Their ValuePayers like key traits of pragmatic clinical trials, but are wary of pharmaceutical companies and plan to carefully scrutinize this new, appealing type of evidence.
Latest:
Prescription Opioid Abuse: Challenges and Opportunities for PayersThis article outlines strategies insurers can use to mitigate their risks related to prescription opioid abuse by members, while addressing this serious public health problem.
Latest:
Improving Endoscopy Completion: Effectiveness of an Interactive Voice Response SystemAn interactive voice response system is as effective as nurse phone calls for ensuring that patients attend appointments and are adequately prepared for endoscopy examinations.
Latest:
Cancer Care Disparities: Research Regarding Timeliness and Potential CoordinationHealthcare organizations and researchers should challenge themselves to provide increasingly timely data on cancer care disparities, until delays can be remedied as they happen.
Latest:
Crisis Into Opportunity: Can COVID-19 Help Set a Path to Improved Health Care Efficiency?With a “new normal” level of care going forward post coronavirus disease 2019 (COVID-19), the key will be to invest in high-value services while deterring a resurgence of low-value care.
Latest:
A Way Out of the Dismal Arithmetic of Hepatitis C TreatmentThis special issue presents important new peer-reviewed research, covering issues ranging from access and the out-of-pocket costs of a treatment course, to the real-world consequences-both economic and clinical-of failing to treat.
Latest:
Late Diagnosis of Hepatitis C Virus Infection, 2014-2016: Continuing Missed Intervention OpportunitiesLate hepatitis C virus infection diagnosis points to a need for earlier screening and treatment before the onset of severe liver disease leading to high cost and diminished outcomes.
Latest:
Development and Validation of the COVID-19 Hospitalized Patient Deterioration IndexThe authors developed and validated an accurate, well-calibrated, easy-to-implement COVID-19 hospitalized patient deterioration index to identify patients at high or low risk of clinical deterioration.
Latest:
Adjunctive Aripiprazole for Depression: Predictive Value of Early AssessmentIn treatment of depression with adjunctive aripiprazole, early improvement (week 2) was a significant predictor of remission, and lack of improvement was associated with nonremission.
Latest:
Impact of Medical Homes on Quality, Healthcare Utilization, and CostsPatient-centered medical home practices provided better preventive care and disease management with less resource utilization than practices not pursuing PCMH status.
